ONTXW
Onconova Therapeutics Inc
Halal Rating :
Last Price
$0.06
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer. The company's primary focus is on developing small molecule drug candidates that target various signaling pathways involved in cancer cell survival and proliferation.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $57000.0 | $8.59m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $57000.0 | $123.41m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $56000.0 | $5.27m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Onconova Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.